287 related articles for article (PubMed ID: 38397987)
1. Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
Teisseire M; Giuliano S; Pagès G
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397987
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
[TBL] [Abstract][Full Text] [Related]
3. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma.
Meng L; Collier KA; Wang P; Li Z; Monk P; Mortazavi A; Hu Z; Spakowicz D; Zheng L; Yang Y
Cells; 2023 Dec; 13(1):. PubMed ID: 38201238
[TBL] [Abstract][Full Text] [Related]
4. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
5. Connective Tissue Growth Factor and Renal Fibrosis.
Yin Q; Liu H
Adv Exp Med Biol; 2019; 1165():365-380. PubMed ID: 31399974
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
[TBL] [Abstract][Full Text] [Related]
7. Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.
Mason RM
Int J Exp Pathol; 2013 Feb; 94(1):1-16. PubMed ID: 23110747
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma.
Zeng K; Li Q; Wang X; Liu C; Chen B; Song G; Li B; Liu B; Gao X; Zhang L; Miao J
Heliyon; 2024 Jan; 10(1):e23918. PubMed ID: 38226288
[TBL] [Abstract][Full Text] [Related]
10. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
Liu F; Wang P; Sun W; Jiang Y; Gong Q
Front Immunol; 2022; 13():874056. PubMed ID: 35734169
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy.
Lin E; Zhu P; Ye C; Huang M; Liu X; Tian K; Tang Y; Zeng J; Cheng S; Liu J; Liu Y; Yu Y
Front Immunol; 2022; 13():830220. PubMed ID: 35677048
[TBL] [Abstract][Full Text] [Related]
12. Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma.
Kim MC; Jin Z; Kolb R; Borcherding N; Chatzkel JA; Falzarano SM; Zhang W
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831009
[TBL] [Abstract][Full Text] [Related]
13. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma.
Ballesteros PÁ; Chamorro J; Román-Gil MS; Pozas J; Gómez Dos Santos V; Granados ÁR; Grande E; Alonso-Gordoa T; Molina-Cerrillo J
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885091
[TBL] [Abstract][Full Text] [Related]
15. Short Hairpin RNA Knockdown of Connective Tissue Growth Factor by Ultrasound-Targeted Microbubble Destruction Improves Renal Fibrosis.
Wei S; Xu C; Rychak JJ; Luong A; Sun Y; Yang Z; Li M; Liu C; Fu N; Yang B
Ultrasound Med Biol; 2016 Dec; 42(12):2926-2937. PubMed ID: 27597128
[TBL] [Abstract][Full Text] [Related]
16. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract][Full Text] [Related]
17. Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With
Lian BJ; Zhang K; Fang XD; Li F; Dai Z; Chen WY; Qi XP
Front Oncol; 2022; 12():927250. PubMed ID: 35875073
[TBL] [Abstract][Full Text] [Related]
18. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
[TBL] [Abstract][Full Text] [Related]
19. CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.
Ren Y; Du C; Yan L; Wei J; Wu H; Shi Y; Duan H
Drug Des Devel Ther; 2015; 9():4155-71. PubMed ID: 26257513
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis-immune-related gene signature.
Ding G; Wang T; Tang G; Zou Q; Wu G; Wu J
Heliyon; 2024 Jan; 10(1):e23503. PubMed ID: 38170124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
